Earnings Ocugen’s Derivative Gain Flatters the Bottom Line as Investors Weigh $84.6 Million Against a 2027 Readout
Ocugen’s third-quarter 2026 report landed with a headline net loss of $3.598 million, but the figure that did most of the work sat well above the operating line. A $16.562...